Redesigning HVEM Interface for Selective Binding to LIGHT, BTLA, and CD160
- 13 August 2020
- Vol. 28 (11) , 1197-1205.e2
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
- National Institute of General Medical Sciences
This publication has 53 references indexed in Scilit:
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingProceedings of the National Academy of Sciences, 2012
- The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulationImmunological Reviews, 2011
- High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosisLeukemia, 2011
- BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccinationJournal of Clinical Investigation, 2010
- T Cell Intrinsic Heterodimeric Complexes between HVEM and BTLA Determine Receptivity to the Surrounding MicroenvironmentThe Journal of Immunology, 2009
- Unconventional ligand activation of herpesvirus entry mediator signals cell survivalProceedings of the National Academy of Sciences, 2009
- Targeting lymphocyte activation through the lymphotoxin and LIGHT pathwaysImmunological Reviews, 2008
- Computational design of antibody-affinity improvement beyond in vivo maturationNature Biotechnology, 2007
- BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1Nature Immunology, 2003
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993